Effect of Mechanical Debridement and Irrigation With Hypochlorous Acid Wound Management Solution on Methicillin-resistant Staphylococcus aureus Contamination and Healing Deep Dermal Wounds in a Porcine Model
ABSTRACT
BACKGROUND: Wound cleansing is an important component of wound management. PURPOSE: This study was conducted to examine the effect of a wound management solution (WMS) containing hypochlorous acid (HOCl) on methicillin-resistant Staphylococcus aureus (MRSA) and healing when used in conjunction with debridement. METHODS: Nineteen (19) deep reticular dermal wounds (22 mm × 22 mm × 3 mm deep) were created on the paravertebral and thoracic areas of 3 female pigs using a specialized electrokeratome. Wounds were separated by at least 5 cm to 7 cm of unwounded skin and inoculated with MRSA. After 72 hours, all wounds were debrided with a curette and irrigated with either the WMS or sterile saline solution twice per day from day 0 to day 4. Wounds then were irrigated once a day until the completion of the study (day 11). Wound tissue specimens were taken using punch biopsy for microbiological and histological analysis on days 4, 8, and 11 post treatment. Percent of wound epithelialized, epithelial thickness (cell layers µm), white cell infiltrate (1 = absent, 2 = mild, 3 = moderate, 4 = marked, 5 = exuberant), and percent of granulation tissue formation were calculated and assessed. Microbiology and histology results were analyzed for significant differences between treatments and among assessment days using one-way analysis of variance and student t-tests. A P value ≤ .05 was considered significant. RESULTS: The WMS effected a bacterial reduction (P ≤ .05) of more than 2.74 ± 0.43 and 1.03 ± 0.22 Log CFU/g in all assessment days compared with baseline before and after debridement, respectively. Percent epithelialization was significantly different between treatments on day 8, only 78.3% and 67.8% for HOCl and saline, respectively (P ≤ .05). No significant differences between treatments were observed for epithelial thickness or granulation tissue formation. CONCLUSION: The combination of debridement and HOCl wound irrigation can significantly reduce MRSA contamination and facilitate the healing process compared to saline irrigation. Clinical studies are needed to confirm these results.
INTRODUCTION
Patients with diabetes mellitus, among other medical conditions, have a high likelihood to develop chronic wounds, such as foot ulcers.1 These chronic wounds are difficult to heal; the patients’ comorbidities inhibit the wound’s ability to move through each phase of the wound healing process, potentially creating complications, such as amputations.2 These complications increase mortality rates to 39% to 80% after 5 years of wound-related amputations. Hence, proven methods to manage chronic and acute wounds and prevent and manage infections are needed.
According to a literature review specific to burn infection by Norbury et al,3 many infections in burns wounds are caused by antibiotic-resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA). Numerous animal and human studies have shown the presence of biofilms and have demonstrated delayed healing and aberrant inflammatory responses.4 Bacteria within biofilm have been shown to have a 10- to 1000-fold increase in resistance toward conventional antibiotics and antiseptics.5-7 In addition, the close proximity of cells within the biofilm facilitates lateral gene transfer, which aids the passage of resistance genes from cell to cell in bacteria and results in a more uniformly resistant bacterial population.8,9 We have demonstrated in our porcine model that once biofilms are formed they are much more difficult to eradicate as compared to planktonic bacteria.10 Furthermore, an in vivo porcine study by Nusbaum et al11 showed that surgical debridement (curette) had limited ability to mechanically remove bacteria from deep partial-thickness wounds in pigs, suggesting that adjunctive thereapies are needed after debridement. Snyder et al12 advocate that appropriate topical antimicrobial application be used after debridement to suppress biofilm reformation.
Wilkins et al13 found that appropriate wound cleaning of clinical wounds removes necrotic tissue and can enhance wound healing. Various irrigation methods have been shown to provide both mechanical and chemical activity. Wound irrigation using hypochlorous acid (HOCl) has been shown, in a clinical study (n = 12) for skin split graft in acute wounds, to have antimicrobial activity without irritating the skin.14 A preliminary clinical study15 testing the ocular, skin, and wound sensitivity against HOCl found that low-level concentrations of the agent are not cytotoxic. In an in vitro study by Sakarya et al,16 all pathogenic microorganisms were killed within 12 seconds after HOCl exposure.
The polyatomic compound derived from HOCl (hypochlorite [ClO-]), has been reported and shown to have positive results in the presence of biofilm in dentistry17,18 and plastic surgery.19,20 The protonated form found in HOCl has been found in 30 clinical case studies treating chronic nonhealing wounds to be 80 to 100 times more effective as an antimicrobial than its ClO- (hypochlorite anion) counterpart.21 In addition, the force created by the irrigation and the antimicrobial capabilities of HOCl have been shown to decrease the bacterial count on both biofilm and planktonic forms against pathogens on surfaces.22
The purpose of this in vivo study was to determine the effect of an HOCl wound irrigation solution on MRSA and healing when used in conjunction with debridement utilizing a well-established biofilm porcine model.23
METHODS
Experimental animals. Three (3) female specific pathogen-free pigs were used as the experimental research animal because swine skin is morphologically similar to human skin.24 The protocol was approved by the University of Miami Animal Use Committee. Animals were monitored daily for any observable signs of pain or discomfort. The animals were provided analgesics during the entire study to help minimize possible discomfort.
Protocol.
Animal preparation and wounding technique. The hair on the flanks and backs of the pigs was trimmed with standard animal clippers, and the areas washed with a nonantibiotic soap (Neutrogena) and deionized sterile water. A specialized electrokeratome was used to create 19 deep reticular dermal wounds (22 mm × 22 mm × 3 mm deep) on the paravertebral and thoracic area on each animal. The wounds were separated by at least 5 cm to 7 cm of unwounded skin. Immediately after wounding, wounds were randomly (block randomization) divided into 2 groups of 8 wounds on each animal; 3 additional wounds were created to obtain baseline counts before treatment.
Wound inoculation. A fresh culture of pathogenic isolate of MRSA was used in these studies. The frozen bacterium was recovered from glycerol stock (15% glycerol in tryptic soy broth [TSB], -80° C). All inoculum suspensions were made by scraping the overnight growth from a culture plate into 5 mL of normal saline. This resulted in a suspension concentration of approximately 108 colony forming units/mL (CFU/mL). The 108 CFU/mL suspension was serially diluted to make an inoculum suspension with a concentration of 106 CFU/mL as determined by optical density at 570 nm. A small amount of the inoculum suspension was plated onto culture media to quantify the exact concentration of viable organisms. A 25 µL aliquot of this suspension was deposited into the center of each wound. Each aliquot then was lightly scrubbed into the test site for 10 seconds using a sterile Teflon spatula and left for 3 minutes before the wounds were covered with a polyurethane film dressing (each wound was dressed individually). Wounds remained covered for 72 hours to allow the biofilms to become established before treatment.10
Treatment regimen. Wounds were debrided once every 72 hours after wound creation and MRSA inoculation using a sterile curette. Using a block randomization method, sets of wounds were randomly assigned to saline (0.9% normal saline, Baxter Healthcare Model) or HOCl (Puracyn Plus, Innovacyn, Inc.) treatment groups. Wounds were rinsed twice using 10-mL syringes with 1.5-inch long, 21-gauge needles held at a 45° angle over the wounds, receiving a total of 20 mL fluid. During wound treatment, the adjacent wounds were covered with sterile 1.5-inch metal caps to prevent the rinse from flowing into the other wounds. After rinsing the wounds, each wound bed was encircled with a sterile cylinder measuring 1¾ inches and the cylinder was simultaneously filled with 4 mL of treatment substance (sterile saline or HOCl) for 5 minutes to fill the entire wound. Any excess treatment was pipetted out. Sterile gauze soaked with 2 mL of treatment of either saline or HOCl then was placed over the wound. All treatments were covered with polyurethane film to retain moisture. Wounds received twice-daily treatments for the first 5 days after debridement and once-daily treatment for the remainder of the study.
Microbiology assessment. Three (3) wounds were cultured 72 hours after wounding and inoculation for baseline enumeration of bacteria using a sterile 6-mm punch biopsy. On days 4, 8, and 11 (after debridement and initial treatment), 2 or 3 additional wounds per group were biopsied from the center of the wound area (6-mm biopsy). Treatment application was not performed on wound to be biopsied. After biopsy recoveries, the remaining wounds not recovered would be then treated.
Biopsy specimens were weighed and immediately placed in 1 mL of all-purpose neutralizing solution. The sample was combined with an additional 4 mL of neutralizing solution and homogenized in a sterile homogenization tube. Serial dilutions were made from all culture samples and the extent of microbiological contamination assessed using the Spiral Plater System (Spiral Biotech). This system deposits a 50 µL aliquot of the scrub bacterial suspension over the surface of a rotating agar plate. Oxacillin resistance screening agar (ORSAB) was used to isolate MRSA USA300. All plates were incubated aerobically overnight (24 hours) at 37° C, after which the number of viable colonies were counted. This method has been used for more than 30 years to evaluate the antimicrobial efficacy of various topical agents and/or dressings.10,25,26
Histological assessment. After treatment application on days 4, 8, and 11, incisional biopsies were obtained through the center of the wounds and included normal adjacent skin on both sides. In a similar fashion to microbiology analysis, treatment application was not performed on wound to be biopsied. After biopsy recoveries, the remaining wounds not recovered then would be treated. These specimens were placed in formalin and then stained with hematoxylin and eosin. One section per block containing the tissue specimens fixated in wax was analyzed. The specimens were evaluated via light microscopy and examined by researchers blinded27 as to treatment groups for the following wound healing elements to determine a potential treatment response:
- Percent of wound epithelialized: measurement of the length of the wound surface covered with epithelium compared with the whole wounded area. The percent of reepithelialization represented the percent of the wound area covered by newly formed epidermis with one or more layers of keratinocytes,27 which has been shown to be a good index for the speed of keratinocyte migration and the first step of the reepithelialization. Percent of epithelialization was calculated dividing length of epithelialized surface by the total length of the wound bed surface multiplied by 100;
- Epithelial thickness (cell layers µm): epithelial thickness may vary from area to area within the biopsy. The thickness of the epithelium in µm was measured on 5 equidistant points from each other in the biopsy and averaged;
- White cell infiltrate: this was a measurement of the presence and amount of subepithelial mixed leukocytic infiltrates. Mean score: 1 = absent, 2 = mild, 3 = moderate, 4 = marked, 5 = exuberant;
- Granulation tissue formation: the approximate amount of new granulation tissue formation (dermis) was graded as follows: 1 = ≤ 5%; 2 = 6% to 25%; 3 = 26% to 50%; 4 = 51% to 75%; and 5 = 76% to 100%.
Statistical analysis. Microbiology and histology results (n = 8) were analyzed for significant differences between treatments and assessment days using one-way analysis of variation (ANOVA) using SPSS, version 22 (IBM), followed by student t-tests. A P value ≤ .05 was considered significant. All treatment results were compared to the baselines and among groups using ANOVA. Student t-test was used to determine the statistical significance among assessment days.
RESULTS
Microbiology analysis. Biopsies that were recovered after debridement alone had significantly lower MRSA counts (6.69 ± 0.38 Log CFU/g) than the biopsies recovered before debridement (8.10 ± 0.60 Log CFU/g) (P ≤ .05). On day 4, wounds irrigated with HOCl had an MRSA count of 5.36 ± 0.17 Log CFU/g, which was significantly lower than wounds irrigated with saline at 6.26 ± 0.31 Log CFU/g (P ≤ .05 (Figure 1).
On day 8, wounds irrigated with HOCl had an MRSA count of 3.66 ± 0.56 Log CFU/g, which was significantly lower than the saline control (5.52 Log CFU/g; P ≤ .05). A bacterial reduction of 98.61% was noted in all assessment times when comparing WMS to saline control. By the end of the study on day 11, wounds irrigated with HOCl exhibited MRSA counts of 3.40 ± 0.51 Log CFU/g, which were significantly (P ≤ .05) lower than saline control (5.21 Log CFU/mL). During all assessment days (4, 8, and 11) wounds treated with the HOCl had significantly lower bacterial counts (P ≤ .05) compared to baseline whereas wounds treated with saline control showed counts lower than baseline wounds only on days 8 and 11 (Figure 2).
Histology results.
Epithelialization. On day 4, all wounds treated with HOCl and saline reached less than 40% of reepithelialization, showing no statistical (P ≤ .05) difference among treatment groups. On day 8, wounds irrigated with HOCl exhibited 78% reepithelialization versus 67% for saline (P ≤ .1). By day 11, the difference in reepitalization was not statistically significant (Figure 3).
Epithelial thickness. Epithelial thickness measurements ranged from 129 µm to 142 µm during the various assessment days, with no significant differences noted between treatment groups (Figure 4).
White cell infiltrate and granulation. When HOCl and saline data were compared, no statistical differences were noted with regard to white cell infiltrate or granulation tissue formation scores during the entire study (Figure 5 and and Figure 6).
DISCUSSION
The results of this study showed that HOCl solution irrigation was superior to saline irrigation of dermal wounds, reducing bacterial counts and increasing the amount of epithelialization when used in conjunction with sharp debridement.
Debridement methods in chronic wounds have proven to be reliable in removing necrotic tissue, and bacterial biofilms from a wound bed.28 A survey29 involving 706 health care professionals specializing in wound care found the vast majority (96%) were completely satisfied with the healing results after performing mechanical debridement on their patients. Hydromechanical therapy (ie, mechanical intervention via debridement with a curette and then spraying a solution into each wound bed) has demonstrated to reduce bacterial presence in previous clinical studies of infected chronic wounds.30 A clinical case31 involving a patient whose nonhealing wound had been treated unsuccessfully for more than 3 months using negative pressure wound therapy showed wound irrigation and mechanical debridement improved wound healing. In the current study, positive outcomes were achieved using either HOCl or saline when compared to baseline bacterial counts (pre and post debridement); HOCl irrigated wounds had lower bacterial levels and higher reepithelialization rates. Other clinical studies have demonstrated similar results; the challenge is to utilize the correct amount of hypochlorite anion concentration within the solution to provide an optimal wound care.32-34
In a clinical study (n = 17) comparing HOCl and saline irrigation in chronic wounds,35 patients whose wounds were treated with HOCl had lower bacterial growth than wounds treated with saline. An in vitro study by Granick et al36 using surfaces of metallic discs composed of titanium and stainless steel, comparable with the alloys used in surgical implants and infected with Staphylococcus epidermidis, showed that ultrasound and HOCl combined treatment completely eradicated S epidermidis when compared to saline.
The current study also demonstrated that wounds irrigated with HOCl achieved more than 97% epithelialization by day 11, and at day 8 the rate of reepithelialization was significantly higher than wounds irrigated with saline (P ≤ .01). In short, wounds irrigated with HOCl had significantly lower bacterial counts and higher healing rates than saline-irrigated wounds. Although the current study was limited to treatment of MRSA-inoculated wounds, an ex vivo study37 using porcine dermal explants found HOCl demonstrated potential antifungal capabilities against C albicans.
Various studies have demonstrated the germicidal properties of HOCl.38-43 A common disinfectant used all over the world, HOCl has theoretical efficacy against bacteria, yeasts, and even viruses such as SARS-CoV.44 The mechanisms by which HOCl affects bacteria has been widely researched.45-47 The interaction of HOCl with sulfur- and heme-containing membrane enzymes and structural proteins48 causes a respiratory loss in the bacterial cell membrane, which leads to a cell death and non-viability.44,45,47,49 An in vitro study by Harriott et al50 testing the reaction of clinical isolates of gram-negative and gram-positive bacteria and Candida (12 species total) to HOCl-based solutions found HOCl to be effective in eliminating bacterial and fungal biofilms. Biofilm disaggregation has been cited as one mechanism responsible for its efficiency against bacteria.51 Biofilm tube experiments with S aureus52 showed that bacterial counts were reduced by >5 logs after a 1-minute exposure to HOCl and 6 logs after 10 minutes; about 70% of the biofilm polysaccharide and > 90% of the biofilm protein also were removed after a 10-minute exposure. Additionally, an in vitro study using human red blood cells53 showed that a low HOCl dosage (300 nmol of HOCl/mL of cell suspension) was enough to be effective against microorganisms without the risk of cytotoxicity. Recent literature confirms the efficacy for HOCl to provide desirable results against gram-positive and gram-negative bacteria, and yeasts during in vitro and in vivo studies.54,55 A retrospective clinical study56 involving 897 patients (44% diagnosed with diabetes mellitus) with 1249 venous ulcers found HOCl can reduce the effects of some comorbidities while accelerating healing times. Most importantly, this clinical study demonstrated the crucial benefits provided when the in tandem protocol involving debridement and HOCl irrigation caused all ulcers to close completely.
One of the limitations of this study and all animal wound models is that they tend to be short term, do not address underlying comorbidities, and do not necessarily replicate a clinical low-grade wound infection.57,58 However, it is widely accepted that porcine skin wound healing most closely resembles the human healing process. A review of 25 wound therapies revealed that porcine studies were in agreement with human-related results 78% of the time compared with 53% and 57% with rodents and in vitro, respectively.26 Consequently, evidence from animal studies is important for clinicians to consider when choosing treatments for chronic wounds, although clinical evidence is still required to validate these findings.
CONCLUSION
The results of this in vitro study showed that the combination of debridement and HOCl wound irrigation can significantly reduce MRSA contamination and facilitate the healing process. This preclinical study suggests that HOCl irrigation in conjunction with surgical debridement techniques may have important clinical benefits in controlling heavily colonized wounds. Clinical studies are needed to elucidate the long-term effect of this treatment strategy on chronic wound healing.
AFFILIATIONS
Mr. Davis is a professor; Mr. Gil is a lab research manager; Dr. Li is an associate professor; and Mr. Simms, Mr. Valdes, Mr. Solis, and Mr. Higa are research associates, University of Miami Miller School of Medicine, Department of Dermatology and Cutaneous Surgery, Miami, FL. Address all correspondence to: Stephen C. Davis, BS, University of Miami Miller School of Medicine, Department of Dermatology and Cutaneous Surgery, PO Box 016250 (R 250), Miami, FL 33101; email: sdavis@med.miami.edu.
References
1. Raghav A, Khan ZA, Labala RK, Ahmad J, Noor S, Mishra BK. Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always. Ther Adv Endocrinol Metab. 2018;9(1):29–31. doi:10.1177/2042018817744513
2. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–228. doi:10.1001/jama.293.2.217
3. Norbury W, Herndon DN, Tanksley J, Jeschke MG, Finnerty CC. Infection in burns. Surg Infect (Larchmt). 2016;17(2):250–255. doi:10.1089/sur.2013.134
4. Percival SL, McCarty SM, Lipsky B. Biofilms and wounds: overview of the evidence. Adv Wound Care. 2015 1;4(7);373–381.
5. Kaehn K, Eberlein T. In-vitro test for comparing the efficacy of wound rinsing solutions. Br J Nurs. 2009;11-24;18(11):S4, S6–8, S10. doi:10.12968/bjon.2009.18.Sup4.42727
6. Prosser BL. Method of evaluating effects of antibiotics on bacterial biofilms. Antimicrob Agents Chemother. 1987;31:1502¬–1506.
7. Pletzer P, Hancock RE. Antibiofilm peptides: potential as broad-spectrum agents. J Bacteriol. 2016;198(19):2572–2578. doi:10.1128/JB.00017-16
8. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol. 2005;13(1):34–40. doi:10.1016/j.tim.2004.11.010
9. Cvitkovitch DG. Genetic competence and transformation in oral streptococci. Crit Rev Oral Biol Med. 2001;12:217–243. doi:10.1177/10454411010120030201
10. Davis SC, Ricotti C, Cazzaniga AL, Welch E, Mertz PM. Microscopic and physiological evidence for biofilm-associated wound colonization in-vivo. Wound Repair Regen. 2008;16(1):23–29. doi:10.1111/j.1524-475X.2007.00303.x
11. Nusbaum AG, Gil J, Rippy MK, et al. Effective method to remove wound bacteria: comparison of various debridement modalities in an in vivo porcine model. J Surg Res. 2012;176(2):701–707. doi:10.1016/j.jss.2011.11.1040.
12. Snyder RJ, Bohn G, Hanft J, et al. Wound biofilm: current perspectives and strategies on biofilm disruption and treatments. Wounds. 2017;29(6):S1–S17.
13. Wilkins RG, Unverdorben M. Wound cleaning and wound healing: a concise review. Adv Skin Wound Care. 2013;26(4):160–163. doi:10.1097/01.ASW.0000428861.26671.4
14. Burian EA, Sabah L, Kirketerp-Møller K, Ibstedt E, Fazli MM, Gundersen G. The safety and antimicrobial properties of stabilized hypochlorous acid in acetic acid buffer for the treatment of acute wounds-a human pilot study and in vitro data. Int J Low Extrem Wounds. 2021;May 5:15347346211015656. doi:10.1177/15347346211015656
15. Wang L, Bassiri M, Najafi R, et al. Hypochlorous acid as a potential wound care agent: part I. Stabilized hypochlorous acid: a component of the inorganic armamentarium of innate immunity. J Burns Wounds. 2007;6:e5
16. Sakarya S, Gunay N, Karakulak M, Ozturk B, Ertugrul B. Hypochlorous acid: an ideal care agent with powerful microbicidal, antibiofilm, and wound healing potency. Wounds. 2014;26(12):342–350.
17. Walsh LJ. Novel approaches to detect and treat biofilm within the root canals of teeth: a review. Antibiotics (Basel). 2020;9(3):129. doi:10.3390/antibiotics9030129
18. Mohammed SA, Vianna ME, Penny MR, Hilton ST, Mordan NJ, Knowles JC. Investigations into in situ Enterococcus faecalis biofilm removal by passive and active sodium hypochlorite irrigation delivered into the lateral canal of a simulated root canal model. Int Endid J. 2018;51(6):649–662. doi:10.1111/iej.12880
19. Fernandez LG, Sibaja Alvarez P, Kaplan MJ, Sanchez-Betancourt AA, Matthews MR, Cook A. Application of negative pressure wound therapy with instillation and dwell time of the open abdomen: initial experience. Cureus. 2019;11(9):e5667. doi:10.7759/cureus.5667
20. Haws MJ, Gingrass MK, Porter RS, Brindle CT. Surgical breast pocket irrigation with hypochlorous acid (HOCl): an in vivo evaluation of pocket protein content and potential HOCl antimicrobial capacity. Aesthet Surg J. 2018;38(11):1178–1184. doi:10.1093/asj/sjy031
21. Crew J, Varilla R, Rocas TA, et al. Neutrophase (®) in chronic non-healing wounds. Int J Burns Trauma. 2012;2(3):126–134.
22. LeChevallier MW, Cawthon CD, Lee RG. Inactivation of biofilm bacteria. Appl Environ Microbiol. 1988;54:2492–2499.
23. Davis SC, Gil J, Solis M, et al. Antimicrobial effectiveness of wound matrices containing native extracellular matrix with polyhexamethylene biguanide. Int Wound J. 2021;May 6. doi:10.1111/iwj.13600
24. Sullivan TP, Eaglstein, Davis SC, Mertz P. The pig as a model for human wound healing. Wound Repair Regen. 2001;9(2):66–76. doi:10.1046/j.1524-475x.2001.00066.x
25. Mertz PM, Davis SC, Cazzaniga A, Drosou A, Eaglstein W. Barrier and antibacterial properties of 2-octyl cyanoacrylate derived wound treatment films. J Cutaneous Med Surg. 2003;7(1):1–6. doi:10.1007/s10227-002-1154-6
26. Mertz PM, Oliveira-Gandia MF, Davis SC. The evaluation of a cadexomer iodine wound dressing on methicllin resistant Staphylococcus aureus (MRSA) in acute wounds Derm Surg. 1999;25:89–93. doi:10.1046/j.1524-4725.1999.08055.x
27. Davis SC, Li J, Gil J, et al. The wound-healing effects of a next-generation anti-biofilm silver Hydrofiber wound dressing on deep partial-thickness wounds using a porcine model. Int Wound J. 2018;15(5), 834–839. https://doi.org/10.1111/iwj.12935
28. Attinger C, Wolcott R. Clinically addressing biofilm in chronic wounds. Adv Wound Care (New Rochelle). 2012;1(3):127–132. doi:10.1089/wound.2011.0333.
29. Roes C, Calladine L, Morris C. Biofilm management using monofilament fibre debridement technology: outcomes and clinician and patient satisfaction. J Wound Care. 2019;28(9):608–622. doi:10.12968/jowc.2019.28.9.608
30. Bekara F, Vitse J, Fluieraru S, et al. New techniques for wound management: a systematic review of their role in the management of chronic wounds. Arch Plast Surg. 2018;45(2):102-110. doi:10.5999/aps.2016.02019
31. Desjardins H, Guo L. An overlooked but effective wound care methodology: hydromechanical therapy revisited. Plast Resconstr Surg Glob Open. 2018;6(8):e1883. doi:10.1097/GOX.0000000000001883.
32. Day A, Alkhalil A, Carney BC, Hoffman HN, Moffatt LT, Shupp JW. Disruption of biofilms and neutralization of bacteria using hypochlorous acid solution: an in vivo and in vitro evaluation. Adv Skin Wound Care. 2017;30(12);543–551. doi:10.1097/01.ASW.0000526607.80113.66
33. Romanowski EG, Stella NA, Yates KA, Brothers KM, Kowalski RP, Shanks RMQ. In vitro evaluation of a hypochlorous acid hygiene solution on established biofilms. Eye Contact Lens. 2018;44(suppl 2):S187–S191. doi:10.1097/ICL.0000000000000456
34. Anagnostopoulos AG, Rong A, Miller D, et al. 0.01% hypochlorous acid as an alternative skin antiseptic: an in vitro comparison. Dermatol Surg. 2018;44(12):1489–1493. doi:10.1097/DSS.0000000000001594
35. Hiebert JM, Robson MC. The immediate and delayed post-debridement effects on tissue bacterial wound counts of hypochlorous acid versus saline irrigation in chronic wounds. Eplasty. 2016;16:e32.
36. Granick MS, Paribathan C, Shanmugan M, Ramasubbu N. Direct-contact low-frequency ultrasound clearance of biofilm from metallic materials. Eplasty. 2017;17:e13.
37. Zmuda HM, Mohamed A, Raval YS, et al. Hypochlorous acid-generating electrochemical scaffold eliminates Candida albicans biofilms. J Appl Microbiol. 2020;129(4):776-786. doi:10.1111/jam.14656
38. Davis SC, Mertz PM. Treatment of wounds with an oak bark formulation: antimicrobial and wound healing assessments. Ostomy Wound Manage. 2008;54(10):16–25.
39. Fuqua WC, Winans SC, Greenberg EP. Quorum sensing in bacteria: the LuxR-Luxl family of cell density responsive transcriptional regulators. J Bacteriol. 1994;176:269–275. doi:10.1128/jb.176.2.269-275.1994
40. Kettle AJ, Winterbourn CC. Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Rep. 1997;3:3–15. doi:10.1080/13510002.1997.11747085
41. Aratani Y. [Role of myeloperoxidase in the host defense against fungal infection.] Nippon Ishinkin Gakkai Zasshi. 2006;47(3):195–199. doi:10.3314/jjmm.47.195
42. Lapenna D, Cuccurullo F. Hypochlorous acid and its pharmacological antagonism: an update picture. Gen Pharmacol. 1996;27:1145–1147. doi:10.1016/s0306-3623(96)00063-8
43. White GC. Handbook of Chlorination and Alternative Disinfectants. 4th ed. New York: Wiley Interscience; 1999.
44. Dellano C, Vega Q, Boesenberg D. The antiviral action of common household disinfectants and antipseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus. Am J Infect Control. 2009;37(8):649–652. doi:10.1016/j.ajic.2009.03.012
45. McKenna SM, Davies KJ. The inhibition of bacterial growth by hypochlorous acid. Possible role in the bactericidal activity of phagocytes. Biochem J. 1988;254(3):685–692. doi:10.1042/bj2540685
46. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001;14(2):244–269. doi:10.1128/CMR.14.2.244-269.2001
47. Young SB, Setlow P. Mechanisms of killing of Bacillus subtilis spores by hypochlorite and chlorine dioxide. J Appl Microbiol. 2003;95(1):54–67. doi:10.1046/j.1365-2672.2003.01960.x
48. Environmental Protection Agency. EPA draft document: drinking water criteria document for chlorine, hypochlorous acid and hypochlorite ion. 1993. Chlorine (CASRN 7782-50-5) | IRIS | US EPA, 1994. https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0405_summary.pdf
49. Heggers JP, Sazy JA, Stenberg BD, et al. Bactericidal and wound-healing properties of sodium hypochlorite solutions: the 1991 Lindberg Award. J Burn Care Rehabil. 1991;12(5):420–424. doi:10.1097/00004630-199109000-00005
50. Harriott MM, Bhindi N, Kassis S, et al. Comparative antimicrobial activity of commercial wound care solutions on bacterial and fungal biofilms. Ann Plast Surg. 2019;83(4):404–410. doi:10.1097/SAP.0000000000001996.
51. Attinger C, Wolcott R. Clinically addressing biofilm in chronic wounds. Adv Wound Care (New Rochelle). 2012;1(3):127–132. doi:10.1089/wound.2011.0333
52. Sauer K, Thatcher E, Northey R, Gutierrez AA. Neutral super-oxidized solutions are effective in killing P. aeruginosa biofilms. Biofouling. 2009;25(1):45–54. doi:10.1080/08927010802441412
53. Vissers MC, Winterbourn CC. Oxidation of intracellular glutathione after exposure of human red blood cells to hypochlorous acid. Biochem J. 1995;307(Pt 1):57–62. doi:10.1042/bj3070057
54. Robson MC. Treating chronic wounds with hypochlorous acid disrupts biofilm. Today’s Wound Clinic. 2014;8(9):20–21.
55. Armstrong DG, Bohn G, Glat P, et al. Expert recommendation for the use of hypochlorous solution: science and clinical application. Wounds. 2015;61(5):S2–S19.
56. Bongiovanni CM. Effects of hypochlorous acid solutions on venous leg ulcers (VLU): experience with 1249 VLUs in 897 patients. J Am Coll Clin Wound Spec. 2014;6(3):32–37. doi:10.1016/j.jccw.2016.01.001
57. Schultz G, Bjarnsholt T, James GA, et al. Consensus guidelines for the identification and treatment of biofilms in chronic nonhealing wounds. Wound Repair Regen. 2017;25(5):744–757. doi: 10.1111/wrr.12590
58. Ganesh K, Sinha M, Mathew-Steiner SS, Das A, Roy S, Sen CK. Chronic wound biofilm model. Adv Wound Care. 2015;4(7):382–388. doi: 10.1089/wound.2014.0587.